Form 4: Elevance Health CEO Gail Boudreaux Reports Stock Transactions
SEC Form 4
Elevance Health's CEO, Gail Boudreaux, reports acquisition and disposal of company stock and derivative securities.
Summary
- Gail Boudreaux, the President and CEO of Elevance Health, filed a Form 4 detailing changes in her beneficial ownership of the company's stock.
- On March 3, 2025, she disposed of 10,396 shares of common stock to cover tax liabilities at a price of $395.5 per share.
- On the same day, she acquired 10,620 restricted share units and 15,587 performance-based restricted share units, both at $0.
- Boudreaux also acquired an option to purchase 40,429 shares of common stock at an exercise price of $395.5, exercisable in installments starting March 3, 2026.
- Following these transactions, Boudreaux directly owns 142,520 shares of common stock and indirectly owns 60 shares held in her spouse's revocable trust.
- She also directly owns options for 40,429 shares.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock transactions. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency into executive compensation and stock ownership.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's future prospects.
Stakeholder Impact
- Shareholders can use this information to understand the CEO's stake in the company.
- Employees may be interested in the details of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of stock disposal, acquisition of restricted share units, and acquisition of stock options. |
| 03/03/2026 | First vesting date for restricted share units (3,540 shares) and first exercisable date for stock options (13,476 shares). |
| 03/03/2027 | Second vesting date for restricted share units (3,540 shares). |
| 03/03/2028 | Third vesting date for restricted share units (3,540 shares). |
| 03/03/2035 | Expiration date for the stock options. |
| 03/05/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.